Influenza and Coronavirus Demise Could Lie with Phage Nanoparticles

April 13, 2020 | Biotechnology

Reading time: 4 minutes

Sourced by Lab.Equipment from GEN, here is this week's Biotech industry article for you:

Given the current global viral pandemic, it wouldn’t be difficult for most to think of viruses in only a negative context. However, over the past several years, a slew of researchers and data has come to light on the benefits of using phage viruses as therapeutic options. Now, a team of investigators led by scientists at the Leibniz-Forschungsinstitut for Molecular Pharmacology (FMP) and Humboldt University (HU) has found a new use for phage in the fight against seasonal influenza and avian flu. The researchers developed a chemically modified phage capsid that “stifles” influenza viruses. Perfectly fitting binding sites cause influenza viruses to be enveloped by the phage capsids in such a way that it is practically impossible for them to infect lung cells any longer. This phenomenon has been proven in preclinical trials using human lung tissue and is being used for the immediate investigation of coronavirus infections... Want to read more? Visit the GEN​ Blog.

Supervising Biotech quality testing applications and scouting for robust biotech lab equipment for your facility? Trust Lab.Equipment for a wide selection of biotech equipment from globally trusted brands such as Hermle and Ohaus. Find lab balances, pipettes, centrifuges, and more recommended for different biotech quality control tests here.

Focusing on forensics, environmental, pharmaceutical applications? Count on Lab.Equipment to enhance your efficiency. Get accurate lab equipment no matter for what application here.

Back To Top
We are fully compliant with the GDPR laws. We promise to safeguard your data and protect your privacy rights.